Kennan C. Marsh
AbbVie (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, HIV/AIDS drug development and treatment, HIV Research and Treatment, Nicotinic Acetylcholine Receptors Study, Pain Mechanisms and Treatments
Most-Cited Works
- → ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets(2013)2,976 cited
- → ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor(2008)1,942 cited
- → ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models(2007)764 cited
- → Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria(1995)599 cited
- → ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.(1995)553 cited
- → A-803467, a potent and selective Na v 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat(2007)519 cited